CytoTools AG
Simbol: T5O.DE
XETRA
0.406
EURTržna cena danes
-4.2935
Razmerje P/E
0.0000
Razmerje PEG
2.02M
Kapaciteta MRK
- 0.00%
Donos DIV
CytoTools AG (T5O-DE) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5.84 | 1.8 | 0 | 1.6 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | -0.2 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.other-current-assets | 0.27 | 0.1 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.total-current-assets | 6.24 | 2 | 0.1 | 1.7 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 79.62 | 19.7 | 18.2 | 20.5 | ||||||||||||||
balance-sheet.row.tax-assets | -20.16 | 0 | 0 | 20.6 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0.53 | -19.7 | -18.2 | -20.6 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 79.66 | 19.7 | 18.2 | 20.6 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 85.89 | 21.6 | 18.3 | 22.3 | ||||||||||||||
balance-sheet.row.account-payables | 0.16 | 0 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 0.1 | 0 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 0 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.08 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0.28 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0.33 | 0.1 | 0.2 | 0.3 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-liab | 0.77 | 0.2 | 0.4 | 0.4 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 20.55 | 5.1 | 4 | 4 | ||||||||||||||
balance-sheet.row.retained-earnings | -86.42 | -21.4 | -20.6 | -16.6 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 76.34 | 0.4 | 0.4 | 34.5 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 74.59 | 37.3 | 34 | 0 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 85.05 | 21.4 | 17.9 | 21.9 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 85.82 | 21.6 | 18.3 | 22.3 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-equity | 85.05 | 21.4 | 17.9 | 21.9 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 85.82 | - | - | - | ||||||||||||||
Total Investments | 79.62 | 19.7 | 18.2 | 20.3 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 0.1 | 0 | ||||||||||||||
balance-sheet.row.net-debt | -5.84 | -1.8 | 0.1 | -1.6 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -0.66 | -0.8 | -4.1 | -1.8 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 2.5 | 0 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0.01 | -0.1 | -0.1 | 0.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.inventory | 0.01 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -0.1 | -0.1 | 0.2 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0.07 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -0.58 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.1 | 0 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1.5 | 0 | -4.8 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-investing-activites | -1.97 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -1.97 | -1.5 | -0.1 | -4.8 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -0.1 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 4.4 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-financing-activites | -0.16 | 0 | 0 | 6 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -0.16 | 4.2 | 0 | 6 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | -2.72 | 1.8 | -1.7 | -0.4 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | -2.72 | 1.8 | -0.1 | 1.6 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 0 | 1.6 | 2 | ||||||||||||||
cash-flows.row.operating-cash-flow | -0.58 | -0.9 | -1.6 | -1.7 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -0.1 | 0 | ||||||||||||||
cash-flows.row.free-cash-flow | -0.58 | -0.9 | -1.7 | -1.7 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0.02 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0.5 | 0.7 | ||||||||||||||
income-statement-row.row.gross-profit | 0.02 | 0 | -0.5 | -0.7 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.operating-expenses | 0.71 | 0.8 | 1.6 | 1.1 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0.71 | 0.8 | 1.6 | 1.9 | ||||||||||||||
income-statement-row.row.interest-income | 0.02 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.02 | 0 | -2.5 | 0 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0.02 | 0 | -2.5 | 0 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 2.5 | 0 | ||||||||||||||
income-statement-row.row.ebitda-caps | -0.68 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | -0.69 | -0.8 | -1.6 | -1.8 | ||||||||||||||
income-statement-row.row.income-before-tax | -0.66 | -0.8 | -4 | -1.8 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.net-income | -0.66 | -0.8 | -4.1 | -1.8 |
Pogosto zastavljeno vprašanje
Kaj je CytoTools AG (T5O.DE) skupna sredstva?
CytoTools AG (T5O.DE) skupna sredstva so 21607950.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 12412.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 1.000.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -0.082.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -29.508.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -30.361.
Kaj je CytoTools AG (T5O.DE) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -829837.250.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 0.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 835230.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 1081631.000.